Hyperammonemia and chronic hepatic encephalopathy: An in vivo PMRS study of the rat brain

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 10, Issue 3, 2000, Pages 160-166

  Astore, D ^a   Boicelli, C A ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Ammonium; Chronic hepatic encephalopathy; Free Mg2+; In vivo PMRS; Phosphates

Indexed keywords

AMMONIUM ACETATE; CREATINE PHOSPHATE; MAGNESIUM; NUCLEOSIDE MONOPHOSPHATE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; MALE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PORTOCAVAL SHUNT; PRIORITY JOURNAL; RAT;

AMMONIA; ANIMALS; BRAIN; CHRONIC DISEASE; ENERGY METABOLISM; HEPATIC ENCEPHALOPATHY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NUCLEOTIDES; PHOSPHATES; PHOSPHOCREATINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034087001     PISSN: 13528661     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1352-8661(00)00083-1     Document Type: Article

References (41)

1. Cooper J.L., Plum F. Biochemistry and physiology of brain ammonia. Physiol. Rev. 67:1987;440-507.
2. Jessy J., Mans A.M., DeJoseph M.R., Hawkins R.A. The hyperammonaemia causes many of the changes found after portacaval shunting. Biochem. J. 273:1990;311-317.
3. Butterworth R.F. The neurobiology of hepatic encephalopathy. Semin. Liver Dis. 16:1996;235-244.
4. Kanamori K., Ross B.D., Chung J.C., Kuo E.L. Severity of hyperammonemic encephalopathy correlates with brain ammonia level and saturation of glutamine synthetase in vivo. J. Neurochem. 67:1996;1584-1594.
5. Vogels B.A.P.M., Vansteynen B., Maas M.A.W., Jorning G.G.A., Chamuleau R.A.F.M. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonemia induced encephalopathy. J. Hepatology. 26:1997;387-395.
6. Jurgens P. New aspects on ethiology, biochemistry and therapy of portal systemic encephalopathy: a critical survey. Nutrition. 13:1997;560-570.
7. 31P-NMR spectroscopy of energy rich phosphates in the brain of the hyperammonemic rat. Biochem. Biophys. Res. Commun. 159:1989;815-820.
8. Fitzpatrick S.M., Hetherington H.P., Behar K., Shulman R.G. Effect of acute hyperammonemia on cerebral amino acid metabolism and ph in vivo measured by 1h and 31p nuclear magnetic resonance. J. Neurochem. 52:1989;741-749.
9. 31P nuclear magnetic resonance study. J. Neurochem. 53:1989;102-110.
10. Seery J.P., Taylor-Robinson S.D. The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy. J. Hepatol. 25:1996;988-998.
11. 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J. Neurochem. 71:1998;1564-1576.
12. Mullen K.D., Birginsson S., Gacad R.C., Conjeevaran H. Animal models of hepatic encephalopathy and hyperammonemia. Adv. Exp. Med. Biol. 368:1994;1-10.
13. Hawkins P.A., De Joseph M.R., Vina J.R., Hawkins R.A. Comparison of the metabolic disturbance caused by end-to-side and side-to-side portacaval shunt. J. Appl. Physiol. 80:1996;885-891.
14. Lopez L., Burgos L., Santin L.J., Begega A., Arias J., Lorente L., Arias J.L. Portacaval shunt control animals - physiological consequences derived from the sham operation. Lab. Anim. 31:1997;225-230.
15. Hindfelt B., Plum F., Duffy T.E. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunt. J. Clin. Invest. 59:1977;386-396.
16. Ehrlich M., Plum F., Duffy T.E. Blood and brain ammonia concentration after portacaval anastomosis. Effect of acute ammonia loading. J. Neurochem. 34:1980;1538-1542.
17. Gjedde A., Lockwood A.H., Duffy T.E., Plum F. Cerebral blood flow and metabolism in chronically hyperammonemic rats. Ann. Neurol. 3:1978;325-333.
18. Varian System Operation VNMR Software, version 5.2f, 1996. pp. 225-262.
19. 31PMRS. A new calibration curve based on a mathematical algorithm. Nucl. Magn. Reson. Biomed. 9:1996;24-32.
20. 31P nuclear magnetic resonance spectroscopy. Neurology. 35:1985;781-788.
21. Cady E.B. Determination of absolute concentration of metabolites from NMR spectra. Nucl. Magn. Reson. Basic Principles Progress. 26:1992;250-281.
22. Rudin M., Sauter A. In vivo phosphorus-31 NMR: potential and limitations. Nucl. Magn. Reson. Basic Principles Progress. 26:1992;163-188.
23. 31PMRS: application to the measurement of free intracellular magnesium in vivo. Magn. Reson. Med. 35:1996;174-185.
24. Gilboe D.D., Kintner D.B., Anderson M.E., Fitzpatrick J.H. Jr NMR-based identification of intra- and extra-cellular compartments of the brain pi peak. J. Neurochem. 71:1998;2542-2548.
25. Hindfelt B. The effect of sustained hyperammonemia upon the metabolic state of the brain. Scand. J. Clin. Lab. Invest. 30:1972;245-255.
26. Hindfelt B., Siesj B.K. Cerebral effects of acute ammonia intoxication. II: the effect upon energy metabolism. Scand. J. Clin. Lab. Invest. 28:1971;365-374.
27. Holmin T. The effect of hepatectomy on the energy state and on acid-base variables of the rat brain. Scand. J. Clin. Lab. Invest. 36:1976;423-429.
28. McCandless D.W., Schenker S. Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system. Exp. Brain. Res. 44:1981;325-330.
29. Jayakumar A.R., Sujatha R., Paul V. Effect of ammonia on motor function in adult rats. Brain. Res. Bull. 43:1997;275-278.
30. Bergquist P.B., Heyes M.P., Bugge M., Bengtsson F. Brain quinolonic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge. J. Neurochem. 65:1995;2235-2240.
31. Barbiroli B., Iotti S., Cortelli P., Martinelli P., Lodi R., Carelli V., Montagna P. Low brain intracellular free magnesium in mitochondrial cytopathies. J. Cerebral Blood Flow Metab. 19:1999;528-532.
32. 31P NMR in vivo. Nucl. Magn. Reson. Biomed. 5:1992;53-58.
33. Lehninger A.L., Nelson D.L., Cox M.M. Principles of Biochemistry. 1993;W.H. Freeman&Co, San Francisco. [chapter 13].
34. eq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reaction. J. Biol. Chem. 254:1979;6528-6537.
35. Veech R.L., Randolph Lawson J.W., Cornell N.W., Krebs H.A. Cytosolic phosphorylation potential. J. Biol. Chem. 254:1979;6538-6547.
36. Matsuda T., Dobson G.P., Veech R.L. The Gibbs-Donnan near-equilibium of heart. J. Biol. Chem. 265:1990;20321-20324.
37. 31P shifts of ATP to cerebral hypoxia-ischemia in neonatal rat. Magn. Reson. Med. 33:1995;853-857.
38. Jones E.A., Basile A.S. Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure? Metab. Brain Dis. 13:1998;351-360.
39. Noremberg M.D. Astroglial disfunction in hepatic encephalopathy. Metab. Brain. Dis. 13:1998;319-335.
40. Barbiroli B., Iotti S., Lodi R. Aspects of human bioenergetics as studied in vivo by magnetic resonance spectroscopy. Biochemie. 80:1998;847-853.
41. 31P-MR spectroscopy in patients with mitochondrial cytopathies. Biofactors. 9:1999;253-260.